DTE:XETRDeutsche Telekom AG Analysis
Data as of 2026-06-14 - not real-time
$147.42
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
DTE Energy is trading at $147.42, roughly 8% below its DCF‑derived fair value of $154.14, offering immediate upside potential. The stock sits comfortably above its 20‑day (≈$143.7) and 50‑day (≈$145.2) moving averages and the 200‑day average (≈$139.8), while a bullish MACD histogram (+0.57) and a neutral‑to‑positive RSI (57.6) signal continued momentum. Volume is increasing, supporting the technical strength, and the price is approaching the near‑term resistance at $148.25. Dividend yield stands at 3.11% with a payout ratio of 74%, making the yield attractive for income‑focused investors, though free cash flow is currently negative. Revenue growth of 15.8% and a forward EPS estimate of $8.35 suggest solid earnings expansion. However, the balance sheet is heavily leveraged, with a debt‑to‑equity ratio of over 200 and total debt exceeding $26 bn. Analyst consensus (14 analysts) projects a mean target of $159.25, reinforcing the undervaluation thesis. The utility sector’s defensive nature and the company’s focus on renewable investments and data‑center infrastructure provide a stable backdrop, while the ultra‑low beta (~0.04) indicates minimal market‑wide volatility. Overall, DTE blends growth prospects with dividend appeal, but capital structure concerns temper long‑term optimism.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price above short‑term SMAs and bullish MACD
- 8% upside to DCF fair value
- Increasing volume supporting momentum
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- 15.8% revenue growth and improving forward EPS
- Analyst mean target of $159.25 above current price
- Renewable and data‑center infrastructure investments
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- High debt‑to‑equity ratio and negative free cash flow
- Stable regulated utility earnings and 3.11% dividend yield
- Low beta indicating limited market volatility
Key Metrics & Analysis
Financial Health
Revenue Growth15.80%
Profit Margin7.65%
P/E Ratio24.3
ROE10.42%
ROA2.78%
Debt/Equity218.79
P/B Ratio2.5
Op. Cash Flow$3.3B
Free Cash Flow$-2188124928
Industry P/E20.5
Technical Analysis
TrendNeutral
RSI57.6
Support$139.75
Resistance$148.25
MA 20$143.67
MA 50$145.17
MA 200$139.78
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
Fair Value$154.14
Target Price$159.25
Upside/Downside8.02%
GradeUndervalued
TypeBlend
Dividend Yield3.11%
Risk Assessment
Beta0.04
Volatility21.38%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.